MedPath

study of everolimus for autistic spectrum disorder in tuberous sclerosis

Not Applicable
Conditions
tuberous sclerosis
Registration Number
JPRN-UMIN000024270
Lead Sponsor
niversity of Tsukuba
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
3
Inclusion Criteria

Not provided

Exclusion Criteria

severe mental retardation

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
scale score for autistic spectrum disorder in 24 weeks
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath